chrisvoncsefalvay/vaers-outcomes huggingface dataset:
19 y/o male with no past medical history who presents with dizziness post vaccination. Patient states that this is his first vaccination in a two-dose series. Patient denies previous reactions to vaccinations in the past. Patient denies headache, vision changes, sore throat, difficulty breathing, shortness of breath, itch or rash. NP and Paramedics at patient side. Patient states that he has not had anything to eat since 1 am and drank only a small amount of water. Patient provided with water and a protein bar. Glucose was obtained and measured 225. Patient denies increase thirst, hunger but states that he has lost some weight recently (patient pushes carts at the supermarket sometimes in the sun). Mother states that patient went for a physical today and pending blood work. Patient vitals within normal limits, 133/89 BP, 98% RA, 77 HR, Resp 12. Patient physician office called and notified of elevated glucose here at the vaccination site. The RN states that patient will be seen tomorrow am to obtain further labs. Prior to discharge patient glucose rechecked x2 and measured 99 and 98. NP still instructed patient to keep tomorrows appointment for labs. Patient was monitored for 30 mins with resolution of dizziness. Patient discharged home in stable condition.
-10 min after vaccine, saw spots and was dizzy almost passed out nurses had to run over and put ice on my neck and put my head in between my legs. they had to keep me at the clinic for 45 min and they checked my blood pressure and it was elevated. that night I had horrible back spasms  - next day had numbness and tingling in my left arm, headace stabbing pain in right eye. sore breasts, spotting , racing heart, elevated blood pressure numbness lasted for two days, all other symptoms have continued every day and I am on day 5
This spontaneous report as received from a pharmacist refers to a patient of unknown demographics. No concurrent conditions or medical history were provided. On 07-APR-2016, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 injection (lot # L031459 with expiry date: 30-APR-2017; strength, dose, route and site of administration were unspecified). The administered vaccine underwent the temperature excursion of 70 degree Fahrenheit during 1 month. It was not the case of a "data logger". No concomitant medications were reported. No adverse effect reported. This is one of several reports from the same source. Additional information has been requested.
Pt could not breath and felt swelling of throat. she was given epinephrine by pharmacist where she was getting vaccine done and started to improve. she was told to come to the ED for further evaluation.
Feel so bad; Sickness; Symptoms are unbearable; Cannot eat; Progressively getting worse with terrible nausea/ nausea; Terrible headache / severe headache; Feeling sick; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling sick), DIZZINESS (Dizziness), FEELING ABNORMAL (Feel so bad), ILLNESS (Sickness) and CONDITION AGGRAVATED (Symptoms are unbearable) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  Concomitant products included SAW PALMETTO [SERENOA REPENS] and COLLAGEN for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced MALAISE (Feeling sick), DIZZINESS (Dizziness), NAUSEA (Progressively getting worse with terrible nausea/ nausea) and HEADACHE (Terrible headache / severe headache). On an unknown date, the patient experienced FEELING ABNORMAL (Feel so bad), ILLNESS (Sickness), CONDITION AGGRAVATED (Symptoms are unbearable) and FEEDING DISORDER (Cannot eat). At the time of the report, MALAISE (Feeling sick), DIZZINESS (Dizziness), FEELING ABNORMAL (Feel so bad), ILLNESS (Sickness), CONDITION AGGRAVATED (Symptoms are unbearable), FEEDING DISORDER (Cannot eat), NAUSEA (Progressively getting worse with terrible nausea/ nausea) and HEADACHE (Terrible headache / severe headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided by reporter.
pt recv vax 19FEB98 along w/other immunizations;pt returned to office on 28FEB98 w/dx of chickenpox (universal);advised to try baking soda bath for relief;
Diffuse papular eruption, simultaneously developing over 24 hrs on extremities and trunk.
8/21/2022- Presents to ED form group home, covid + h. Covid + home test and feels SOB and cough. Also noted blood  in stool, pmh of GI bleeds, 2 units ordered HGb 6.8.  currently on Protonix, f/u with GI outpatient UTD with colonoscopy.Covid + test. CXr-no acute pulmonary disease. Afebrile, BP-87/54. O2 sat WNL. WBC-5.5  8/22/2022-Hgb 8.2, VSS , o2 sat WNL. D/C home with Paxlovid.
Dx: Myopericarditis Tx: Ibuprofen 800mg  4 weekTaper, Cochicine 6 month taper S/Sx: Dyspnea on exertion, chest pressure
Body aches; left arm pain at the site of the injection; A spontaneous report was received from a healthcare professional concerning a male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events left arm pain at the site of the injection, body aches.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 4 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 013A21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 4 Mar 2021, the patient experienced the event(s) left arm pain at the site of the injection, body aches.  Treatment details included None.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), left arm pain at the site of the injection, body aches was unknown.
Injection site severe bruising.  Below injection site, from left shoulder down arm until elbow, extremely red itchy, swollen in an oval shape.
High blood pressure spike 186/81; Rapid heart rate; Difficulty breathing; I had a visual aura I saw a big red ball with my eyes closed; Arm soreness; trembly; dry mouth; weak; A spontaneous report was received from a consumer concerning a 77-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events high blood pressure spike 186 81, rapid heart rate, difficulty breathing, a visual aura i saw a big red ball with my eyes closed, arm soreness, weak, trembly, dry mouth.  The patient's medical history was not provided. Concomitant medications reported were Lotrel 5/10mg for drug use for unknown indication.  On 3 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) high blood pressure spike 186 81, rapid heart rate, difficulty breathing, a visual aura I saw a big red ball with my eyes closed, arm soreness, weak, trembly, dry mouth.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), high blood pressure spike 186 81, rapid heart rate, difficulty breathing, i had a visual aura i saw a big red ball with my eyes closed, arm soreness, weak, trembly, dry mouth was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Had a covid arm; Redness; Itchiness; 100 degree fever; soreness at injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (Had a covid arm), ERYTHEMA (Redness), PRURITUS (Itchiness), PYREXIA (100 degree fever) and VACCINATION SITE PAIN (soreness at injection site) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 04262A and 003A21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, AMLODIPINE, LEVOTHYROXINE, ALENDRONATE SODIUM (ALENDRONATE), BUSPIRONE and BACLOFEN for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Had a covid arm), ERYTHEMA (Redness), PRURITUS (Itchiness), PYREXIA (100 degree fever) and VACCINATION SITE PAIN (soreness at injection site). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (Had a covid arm), ERYTHEMA (Redness), PRURITUS (Itchiness), PYREXIA (100 degree fever) and VACCINATION SITE PAIN (soreness at injection site) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100 (High) 100 degree fever.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Other treatment medication included Steroid cream, for Adverse event.
Hx of COPD, CHF, HTN, arthritis and positive for COVID; sent to ICU with AHRF, acute on chronic kidney disease; EMS reports pt's O2 sats on RA were 55%, placed on CPAP with little improvement; in ED pt placed on BiPAP; experienced CVA, shock, multisystem organ failure, GI bleed; vasopressors; pt went into asystole, ACLS protocol initiated but pt died in the hosp
My father reported pain in his back/side he also reported feeling lethargic and fatigued. Ongoing he lost appetite he legs swelled with fluid as did his legs. He consistently Experienced diarrhoea from the point of the 1st and 2nd shots and this continued onwards. He dropped an estimated 4 stone in weight and became bed ridden.
This case was reported by a consumer via call center representative and described the occurrence of shingles in a 77-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included ZOSTAVAX (received at the age of 60 years). On 26th May 2018, the patient received the 1st dose of SHINGRIX. On 8th October 2018, 135 days after receiving SHINGRIX, the patient experienced shingles, discomfort, raised rash, localized erythema, itchy rash and sunburn-like rash. On 12th October 2018, the patient experienced injected limb mobility decreased and painful rash. In October 2018, the patient experienced shooting pain. The patient was treated with VALTREX. On an unknown date, the outcome of the shingles, discomfort, injected limb mobility decreased, itchy rash, painful rash and sunburn-like rash were unknown and the outcome of the raised rash was recovered/resolved and the outcome of the localized erythema and shooting pain were not recovered/not resolved. It was unknown if the reporter considered the shingles, discomfort, injected limb mobility decreased, raised rash, localized erythema, itchy rash, painful rash, sunburn-like rash and shooting pain to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient for himself. The patient received SHINGRIX in the right arm. On 8th October 2018, the patient noticed itch on the back of his right shoulder. There were two red spots. This spread to his front right shoulder, the right side of his chest, under his right arm pit, and the right side of his back. These areas were itchy. The patient said that there was a lot of discomfort and it felt like a sunburn. By Monday and Tuesday before the date of reporting, the spots, which he now referred to as a rash, became raised. He went to his family physician on Friday, 12th October 2018 and was prescribed VALTREX. The rash was very painful on Friday, Saturday and Sunday, forcing him to have to sleep upright because he could not lay on the rash and he could not lift his right arm. On 15th October 2018, he has significantly less pain (60-70 percent resolved). On the date of reporting, there was less pain than on Monday, redness was still present but the rash was no longer raised. Every now and then he gets a shooting pain that will last for 2-3 seconds, causing him to flinch and then it was gone.
discomfort in her eyes; Take naps/slept 10 hours last night; Gained 10 lbs after the 2nd dose in this 6 months.; Brain fog; Cannot handle stress anymore; Real bad side effects ever since the 2nd dose; Fatigue which is still ongoing after 6 months/severe fatigue; stabbing pain in both her eyes/feels like strain in eyes all the time/wears reading glasses a lot now/eye pain; developed photophobia; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (stabbing pain in both her eyes/feels like strain in eyes all the time/wears reading glasses a lot now/eye pain), PHOTOPHOBIA (developed photophobia), OCULAR DISCOMFORT (discomfort in her eyes), SOMNOLENCE (Take naps/slept 10 hours last night) and WEIGHT INCREASED (Gained 10 lbs after the 2nd dose in this 6 months.) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced EYE PAIN (stabbing pain in both her eyes/feels like strain in eyes all the time/wears reading glasses a lot now/eye pain) and PHOTOPHOBIA (developed photophobia). On an unknown date, the patient experienced OCULAR DISCOMFORT (discomfort in her eyes), SOMNOLENCE (Take naps/slept 10 hours last night), WEIGHT INCREASED (Gained 10 lbs after the 2nd dose in this 6 months.), FEELING ABNORMAL (Brain fog), STRESS (Cannot handle stress anymore), VACCINATION COMPLICATION (Real bad side effects ever since the 2nd dose) and FATIGUE (Fatigue which is still ongoing after 6 months/severe fatigue). The patient was treated with PREDNISOLONE at an unspecified dose and frequency. At the time of the report, EYE PAIN (stabbing pain in both her eyes/feels like strain in eyes all the time/wears reading glasses a lot now/eye pain), PHOTOPHOBIA (developed photophobia), OCULAR DISCOMFORT (discomfort in her eyes), SOMNOLENCE (Take naps/slept 10 hours last night), WEIGHT INCREASED (Gained 10 lbs after the 2nd dose in this 6 months.), FEELING ABNORMAL (Brain fog), STRESS (Cannot handle stress anymore), VACCINATION COMPLICATION (Real bad side effects ever since the 2nd dose) and FATIGUE (Fatigue which is still ongoing after 6 months/severe fatigue) outcome was unknown.            The concomitant medications were not reported   This case was linked to MOD-2021-293207 (Patient Link).
Headache; Itchness at the injection site; Redness at the injection site; Tingling sensation at the injection site; Heaviness at the injection site; Soreness at the injection site; Fatigue; This spontaneous case was reported by an other health care professional and describes the occurrence of PARAESTHESIA (Tingling sensation at the injection site), LIMB DISCOMFORT (Heaviness at the injection site), HEADACHE (Headache), VACCINATION SITE PRURITUS (Itchness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced FATIGUE (Fatigue). On 12-Jan-2021, the patient experienced PARAESTHESIA (Tingling sensation at the injection site), LIMB DISCOMFORT (Heaviness at the injection site), VACCINATION SITE PRURITUS (Itchness at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE PAIN (Soreness at the injection site). On 11-Mar-2021, the patient experienced HEADACHE (Headache). At the time of the report, PARAESTHESIA (Tingling sensation at the injection site), LIMB DISCOMFORT (Heaviness at the injection site), HEADACHE (Headache), VACCINATION SITE PRURITUS (Itchness at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
FEVER, LOST OF TASTE/SMELL, HEADACHE, BODY ACHES
A report has been received from a Health Professional concerning a 6 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on 31-Dec-2013. The reporter stated that inadvertently administered expired FLUMIST QUADRIVALENT which started on 31-Dec-2013. The outcome of the event of inadvertently administered expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious by the reporter.
I believe I'm being asked to fill this form out because I reported getting Shingles (~5 months after my last COVID vaccination) on my v-safe check-in questionnaire. The Shingles symptoms started with pain on my right side, wrapping around my abdomen, and a few days later the red rash appeared. I had a video visit with a Dr. who prescribed an anti-viral medication that I began approx. 6 days after the pain started. The medication seemed to help slow the spread, but discomfort persisted for 3-4 weeks until the rash scabbed over and symptoms decreased.
Right ankle swollen; Right ankle painful; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever), JOINT SWELLING (Right ankle swollen) and ARTHRALGIA (Right ankle painful) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In February 2021, the patient experienced CHILLS (Chills) and PYREXIA (Fever). On an unknown date, the patient experienced JOINT SWELLING (Right ankle swollen) and ARTHRALGIA (Right ankle painful). At the time of the report, CHILLS (Chills), PYREXIA (Fever), JOINT SWELLING (Right ankle swollen) and ARTHRALGIA (Right ankle painful) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: showed no inflammation rheumatoid arthritis Showed no inflammation rheumatoid arthritis those markers were fantastic.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       HUMIRA(Solution for injection in pre-filled pen) was given as citrate free for moderate to severe RA.The reporter causality for events with Humira was no reasonable probability. Concomitant drugs were not reported. Treatment information was not provided. On an unknown date blood work was done which showed no inflammation, rheumatoid arthritis those markers were fantastic. It was unknown if patient was enrolled in COVID-19 clinical trial.   This case was linked to MOD-2022-570161, MOD-2022-570179 (Patient Link).
This non-valid, spontaneous report was received from a registered nurse, referring to an unspecified number of patients of unknown age and gender. No information was provided regarding the patients' medical history, previous drug reactions, allergies, concurrent medical conditions or concomitant medications. On unknown dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB lot number N034005 (expiration date 31-JAN-2020) and lot number reported as "N021920" (expiration date 07-FEB-2020) for prophylaxis (doses, routes and anatomical locations of administration were not reported). Additionally, the patients were vaccinated with ROTATEQ by oral route, lot number N005078 (expiration dates 22-NOV-2018 and 04-OCT-2018) for prophylaxis (doses were unknown), GARDASIL 9 lot number N020352 (expiration date 10-APR-2020) for prophylaxis (doses, routes and anatomical locations of administration were not provided) and M-M-R II for prophylaxis (dose numbers, routes and anatomical locations of administration were not provided; lot numbers N010496 [expiration date 31-MAR-2019], N014485 [expiration date 10-MAY-2019], and N023149 [expiration date 24-AUG-2019]). The vaccines were reconstituted with sterile diluent which was reported to be properly stored. The doses of all vaccines were exposed to a temperature excursion below 32 degrees Fahrenheit (F) (also reported as 31F) during a time frame of 15 days, which was detected by the Digital Data Logger. There was no prior temperature excursion and no adverse effects were reported. Follow-up information was received from the nurse on 17-DEC-2018. The reporter provided patients' demographics which made the case valid. This report refers to a 11-year-old patient of unknown gender. On 22-MAY-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 lot number N020352 (expiration date 10-APR-2020). This is one of multiple reports received from the same reporter. Sender's Comments: US-009507513-1807USA011661.
Patient received a dose of Pfizer vaccines 0.2ml, the vaccine was not prepare correctly. The diluent was not added it to the vial. The dose  that patient received was a full dose of the medication.
Swollen in arm; chills; loss of appetite; temporary temp; fatigue lasted for about 3 weeks.
Chills and Hot Flashes, 24 hours/day. Variable times and durations.
Screened pt for COVID booster.  Pt had lost card; looked up pts information in agency entry system which showed that pt had initial doses of Moderna series, but no booster shot.  Re-wrote new COVID card and administered booster.  Later in day upon doing data entry, it is recognized that pt is already in our documenting system but under another date of birth, at the same location, indicating that we may have previously given pt his 1st booster dose 1/10/22 and pt would not be due for 2nd booster until around 5/10/22.  If this data is correct, pt was given 2nd booster shot less than 2 weeks early.
19 patients given 0.25 mL instead of full dose for adults at 0.5 mL; this was discovered on 10/24/22 and all patients were notified 10/25-10/26 after plan for readministration was established.  all patients were encouraged to schedule apt 8 weeks or more after their incorrectly dosed vaccination for repeat vaccination.  No patients reported any adverse reactions to the vaccine.